Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-38456518

ABSTRACT

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, updated strategies for the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 2 of this consensus provides clinicians with an overview of the diagnosis and treatment of scleromyxoedema and scleroedema (of Buschke).

2.
Acta Derm Venereol ; 96(1): 92-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26014511

ABSTRACT

Vulvovaginal-gingival lichen planus (VVG-LP) consists of a triad of symptoms: vulval, vaginal and gingival lichen planus lesions. The aim of this study was to analyse the prevalence of lesions in various anatomical locations in patients with VVG-LP. The study included 126 consecutive patients with lichen planus. Sixteen (12.7%) patients fulfilled the criteria of VVG-LP. In 12/16 (75%) patients with VVG-LP scalp lesions were also observed. Stratified epithelium-specific antinuclear antibodies (SES-ANA) and anti-ΔNp.3α antibodies were detected in 10/16 (75%) patients with VVG-LP and in 15/110 (13.6%) patients with other forms of lichen planus (p < 0.05). In conclusion, VVG-LP is frequently associated with lichen planopilaris. The new entity may be termed "vulvovaginal-gingival-pilar lichen planus" and our study indicates that SES-ANA is a marker of this type of lichen planus with extensive, severe and refractory-to-therapy involvement of the mucous membranes, skin and scalp.


Subject(s)
Antibodies, Antinuclear/analysis , Epithelial Cells/immunology , Gingival Diseases/immunology , Lichen Planus, Oral/immunology , Vaginal Diseases/immunology , Vulvar Diseases/immunology , Adult , Aged , Antibodies, Antinuclear/blood , Biomarkers/analysis , Biopsy , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Gingival Diseases/diagnosis , Gingival Diseases/epidemiology , Humans , Lichen Planus, Oral/diagnosis , Lichen Planus, Oral/epidemiology , Middle Aged , Poland/epidemiology , Prevalence , Terminology as Topic , Vaginal Diseases/diagnosis , Vaginal Diseases/epidemiology , Vulvar Diseases/diagnosis , Vulvar Diseases/epidemiology , Young Adult
3.
Skin Pharmacol Physiol ; 28(4): 213-225, 2015.
Article in English | MEDLINE | ID: mdl-25721772

ABSTRACT

Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) influence hair follicles through paracrine and intracrine routes. There is significant evidence that PTH and PTHrP influence the proliferation and differentiation of hair follicle cells. The PTH/PTHrP receptor signalling plays an important role in the hair follicle cycle and may induce premature catagen-telogen transition. Transgenic mice with an overexpression or blockade (PTH/PTHrP receptor knockout mice) of PTHrP activity revealed impaired or increased hair growth, respectively. Some findings also suggest that PTHrP may additionally influence the hair cycle by inhibiting angiogenesis. Antagonists of the PTH/PTHrP receptor have been shown to stimulate proliferation of hair follicle cells and hair growth. A hair-stimulating effect of a PTH/PTHrP receptor antagonist applied topically to the skin has been observed in hairless mice, as well as in mice treated with cyclophosphamide. These data indicate that the PTH/PTHrP receptor may serve as a potential target for new (topical) hair growth-stimulating drugs, especially for chemotherapy-induced alopecia.


Subject(s)
Hair Follicle/physiology , Parathyroid Hormone/metabolism , Alopecia/chemically induced , Alopecia/drug therapy , Animals , Antineoplastic Agents/adverse effects , Hair/growth & development , Hair/metabolism , Hair Follicle/anatomy & histology , Humans , Parathyroid Diseases/metabolism , Receptor, Parathyroid Hormone, Type 1/metabolism
4.
Virus Genes ; 29(2): 239-47, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15284484

ABSTRACT

Tula virus (TULV), a recently identified arvicolid rodent-borne hantavirus, is harbored by the European common vole (Microtus arvalis) in Central Russia and the Czech and Slovak Republics. We report the isolation and characterization of this hantavirus from M. arvalis captured in Poland, a country where human disease caused by hantaviruses has not been recognized. Of 34 arvicolid rodents (24 Clethrionomys glareolus, 9 M. arvalis, 1 Pitymys sp.) captured in Lodz and Tuszyn, Poland, during June to September 1995, sera from 3 M. arvalis and 3 C. glareolus contained IgG antibodies to Puumala virus (PUUV), as determined by an indirect immunofluorescent antibody assay. Alignment and comparison of the 1852-nucleotide S segment and a 1676-nucleotide region of the G2 glycoprotein-encoding M segment, amplified from lung tissues of two hantavirus-seropositive M. arvalis, revealed 83.9-85.2% and 82.3-83.5% sequence similarity, respectively, with TULV strains from Central Russia and the Czech and Slovak Republics. A > 98% sequence conservation was found at the amino acid level. Phylogenetic analysis indicated that the newly found TULV strains from Poland were closely related to, but distinct from, TULV from elsewhere in Europe.


Subject(s)
Arvicolinae/virology , Hantavirus Infections/veterinary , Orthohantavirus/classification , Orthohantavirus/genetics , Phylogeny , Rodent Diseases/virology , Amino Acid Sequence , Animals , Cluster Analysis , DNA, Viral/analysis , Orthohantavirus/isolation & purification , Hantavirus Infections/virology , Molecular Sequence Data , Nucleocapsid/genetics , Poland
SELECTION OF CITATIONS
SEARCH DETAIL
...